PL3185911T3 - Zestaw do znakowania radioizotopowego 68CA zawierający inhibitor metalu - Google Patents

Zestaw do znakowania radioizotopowego 68CA zawierający inhibitor metalu

Info

Publication number
PL3185911T3
PL3185911T3 PL15748207T PL15748207T PL3185911T3 PL 3185911 T3 PL3185911 T3 PL 3185911T3 PL 15748207 T PL15748207 T PL 15748207T PL 15748207 T PL15748207 T PL 15748207T PL 3185911 T3 PL3185911 T3 PL 3185911T3
Authority
PL
Poland
Prior art keywords
kit containing
metal inhibitor
radiolabeling kit
radiolabeling
inhibitor
Prior art date
Application number
PL15748207T
Other languages
English (en)
Inventor
Ludovic WOUTERS
Geoffroy KAISIN
André LUXEN
Marc LÉONARD
Samuel Voccia
Original Assignee
Anmi S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anmi S.A. filed Critical Anmi S.A.
Publication of PL3185911T3 publication Critical patent/PL3185911T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/008—Peptides; Proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Radiation-Therapy Devices (AREA)
PL15748207T 2014-08-29 2015-07-28 Zestaw do znakowania radioizotopowego 68CA zawierający inhibitor metalu PL3185911T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BE2014/0653A BE1021191B1 (fr) 2014-08-29 2014-08-29 Kit pour radiomarquage.
EP15748207.6A EP3185911B1 (en) 2014-08-29 2015-07-28 Kit for radiolabelling with 68ga comprising a metal inhibitor
PCT/EP2015/067211 WO2016030103A1 (en) 2014-08-29 2015-07-28 Kit for radiolabelling with 68ga comprising a metal inhibitor

Publications (1)

Publication Number Publication Date
PL3185911T3 true PL3185911T3 (pl) 2021-08-23

Family

ID=52396314

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15748207T PL3185911T3 (pl) 2014-08-29 2015-07-28 Zestaw do znakowania radioizotopowego 68CA zawierający inhibitor metalu

Country Status (20)

Country Link
US (7) US11045563B2 (pl)
EP (4) EP3862026A1 (pl)
JP (2) JP6543343B2 (pl)
CN (2) CN106794265B (pl)
AU (7) AU2015309187B2 (pl)
BE (1) BE1021191B1 (pl)
BR (3) BR112017003710B1 (pl)
CA (3) CA3167294C (pl)
DK (1) DK3185911T3 (pl)
ES (2) ES2855991T3 (pl)
FR (1) FR25C1028I1 (pl)
HU (1) HUE053971T2 (pl)
IL (2) IL250736B (pl)
MX (2) MX379367B (pl)
NZ (1) NZ729293A (pl)
PL (1) PL3185911T3 (pl)
PT (1) PT3185911T (pl)
RU (2) RU2724894C2 (pl)
WO (2) WO2016030103A1 (pl)
ZA (1) ZA201702152B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11027030B2 (en) 2014-08-29 2021-06-08 Anmi S.A. Kit for radiolabelling
BE1021191B1 (fr) 2014-08-29 2015-10-27 Anmi S.A. Kit pour radiomarquage.
GB201504064D0 (en) * 2015-03-10 2015-04-22 Accretion Biotechnology Ltd Method and kits for preparing radionuclide complexes
CN106377527B (zh) * 2016-09-05 2019-02-26 郑州大学 开链吡啶羧酸衍生物H2dedpa在抗菌领域的应用
US10093741B1 (en) 2017-05-05 2018-10-09 Fusion Pharmaceuticals Inc. IGF-1R monoclonal antibodies and uses thereof
MA48861A (fr) 2017-05-05 2020-04-01 Fusion Pharmaceuticals Inc Améliorations pharmacocinétiques de chélates bifonctionnels et leurs utilisations
WO2018204872A2 (en) 2017-05-05 2018-11-08 Fusion Pharmaceuticals Inc. Igf-1r monoclonal antibodies and uses thereof
JP7338128B2 (ja) * 2017-12-08 2023-09-05 イー、シー、エス、ビオトラッカー、エス、エー、アール、エル 癌診断における放射性標識プロガストリン
US20210276971A1 (en) * 2018-06-20 2021-09-09 The Research Foundation For The State University Of New York Triazamacrocycle-derived chelator compositions for coordination of imaging and therapy metal ions and methods of using same
CN110787186B (zh) * 2019-10-22 2020-11-17 华中科技大学 一种Ga3+/PDA靶向协同抗菌纳米材料、其制备和应用
IT202000032603A1 (it) 2020-12-29 2022-06-29 Univ Degli Studi Di Bari Aldo Moro Kit freddi a base di ligandi del psma per l’allestimento di radiofarmaci.
EP4347541A2 (en) 2021-05-31 2024-04-10 Telix Pharmaceuticals (Innovations) Pty Ltd Improved prostate-specific membrane antigen targeting radiopharmaceuticals and uses thereof
EP4362989A2 (en) 2021-06-29 2024-05-08 Life Molecular Imaging Limited A novel kit for radiopharmaceutical preparation of a radiometal labeled chelate-functionalized targeting conjugate
WO2025242848A1 (en) * 2024-05-23 2025-11-27 Telix Innovations S.A. Radiolabelling kit and method for radiolabelling with 68ga or 67ga
WO2026013238A2 (en) * 2024-07-12 2026-01-15 Telix Innovations S.A. Radiolabelling kit and method for radiolabelling with zirconium-89

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7902342A (nl) 1979-03-26 1980-09-30 Byk Mallinckrodt Cil Bv Isotopengenerator.
WO2003048207A2 (en) * 2001-11-28 2003-06-12 Immunomedics, Inc. Anti-dota antibody
US7011816B2 (en) * 2001-12-26 2006-03-14 Immunomedics, Inc. Labeling targeting agents with gallium-68 and gallium-67
ES2398393T3 (es) 2002-03-01 2013-03-15 Dyax Corp. Péptidos de unión a KDR y a VEGF/KDR y su uso en diagnóstico y terapia
US7597876B2 (en) * 2007-01-11 2009-10-06 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
GB0308408D0 (en) * 2003-04-11 2003-05-21 Amersham Plc Microwave activation
JP5139678B2 (ja) 2003-07-24 2013-02-06 ブラッコ・イメージング・ソシエタ・ペル・アチオニ 安定な放射性医薬品組成物およびその製法
AU2006204045B2 (en) 2005-01-05 2010-10-14 Board Of Regents, The University Of Texas System Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications
US8545809B2 (en) 2007-01-11 2013-10-01 Immunomedics, Inc. Methods and compositions for improved 18F labeling of proteins, peptides and other molecules
MX340566B (es) 2007-03-27 2016-07-14 Radiomedix Inc Composiciones para formacion de imagen objetivo y terapia.
FR2942227B1 (fr) 2009-02-13 2011-04-15 Guerbet Sa Utilisation de tampons pour la complexation de radionucleides
EP2419123A1 (en) * 2009-04-14 2012-02-22 Humagene, Inc. Novel post-translational fibrinogen variants
WO2010141833A2 (en) 2009-06-05 2010-12-09 The General Hospital Corporation Vital fluorochrome conjugates and methods of use
US8951064B2 (en) 2010-12-14 2015-02-10 Ideal Industries, Inc. Terminal structures for wiring devices
ITFI20110180A1 (it) * 2011-08-12 2013-02-13 Advanced Accelerator Applic S A Processo per la preparazione di complessi di 68ga.
US9161998B2 (en) * 2012-05-18 2015-10-20 Zentralklinik Bad Berka Gmbh Method and kit for preparing a radiopharmaceutical
WO2014066733A2 (en) 2012-10-25 2014-05-01 Life Technologies Corporation Methods and compositions for enzyme-mediated site-specific radiolabeling of glycoproteins
US11027030B2 (en) 2014-08-29 2021-06-08 Anmi S.A. Kit for radiolabelling
BE1021191B1 (fr) 2014-08-29 2015-10-27 Anmi S.A. Kit pour radiomarquage.
CN104830316B (zh) * 2015-05-11 2017-02-01 厦门大学 一种用于核素标记的靶向探针及其制备方法和应用
ITUA20163207A1 (it) 2016-05-06 2017-11-06 Azienda Ospedaliera Di Reggio Emilia Arcispedale Santa Maria Nuova Preparazione in kit di radiofarmaci marcati con gallio-68

Also Published As

Publication number Publication date
CA2958475A1 (en) 2016-03-03
BR112017003710B1 (pt) 2021-12-14
RU2017109583A (ru) 2018-10-01
ES2855991T3 (es) 2021-09-27
CA2958471A1 (en) 2016-03-03
CA2958471C (en) 2022-05-31
WO2016030104A1 (en) 2016-03-03
US20210268131A1 (en) 2021-09-02
AU2015309188B2 (en) 2020-05-21
EP3862026A1 (en) 2021-08-11
RU2725627C2 (ru) 2020-07-03
IL250736B (en) 2021-04-29
US11040120B2 (en) 2021-06-22
EP3185912A1 (en) 2017-07-05
AU2015309188A1 (en) 2017-03-09
IL250735A0 (en) 2017-04-30
AU2020220193A1 (en) 2020-09-10
BR112017003710A2 (pt) 2017-12-05
ZA201702152B (en) 2021-06-30
NZ729291A (en) 2021-03-26
CN106794265A (zh) 2017-05-31
RU2017109582A (ru) 2018-10-01
MX2017002361A (es) 2017-09-15
AU2022202439B2 (en) 2023-12-14
IL250735B (en) 2021-04-29
EP3862025A1 (en) 2021-08-11
US12329829B2 (en) 2025-06-17
FR25C1028I1 (fr) 2025-09-19
CN106659806A (zh) 2017-05-10
BR122021017474B1 (pt) 2023-10-10
HUE053971T2 (hu) 2021-07-28
US20210275697A1 (en) 2021-09-09
US11045563B2 (en) 2021-06-29
AU2024205118B2 (en) 2026-04-09
CN106794265B (zh) 2021-01-26
MX388098B (es) 2025-03-19
AU2022202346A1 (en) 2022-04-28
CA2958475C (en) 2022-07-12
EP3185911B1 (en) 2020-12-30
JP2017530188A (ja) 2017-10-12
US20180230069A1 (en) 2018-08-16
MX2017002362A (es) 2017-09-15
CN106659806B (zh) 2021-01-26
EP3185911A1 (en) 2017-07-05
IL250736A0 (en) 2017-04-30
AU2020220194A1 (en) 2020-09-10
US20220296735A1 (en) 2022-09-22
EP3185912B1 (en) 2020-12-30
JP6552622B2 (ja) 2019-07-31
JP6543343B2 (ja) 2019-07-10
MX379367B (es) 2025-03-11
US20260102524A1 (en) 2026-04-16
ES2856030T3 (es) 2021-09-27
BR112017003578B1 (pt) 2023-12-26
RU2017109582A3 (pl) 2018-12-20
CA3167294C (en) 2024-05-28
WO2016030103A1 (en) 2016-03-03
AU2024205118A1 (en) 2024-08-15
DK3185911T3 (da) 2021-03-15
BE1021191B1 (fr) 2015-10-27
US20180230068A1 (en) 2018-08-16
NZ729293A (en) 2022-04-29
US20220273827A1 (en) 2022-09-01
PT3185911T (pt) 2021-03-22
CA3167294A1 (en) 2016-03-03
AU2022202439A1 (en) 2022-05-05
CA2958471E (en) 2016-03-03
AU2015309187A1 (en) 2017-03-09
RU2724894C2 (ru) 2020-06-26
RU2017109583A3 (pl) 2018-12-26
BR112017003578A2 (pt) 2017-12-05
AU2015309187B2 (en) 2020-05-21
JP2017526745A (ja) 2017-09-14

Similar Documents

Publication Publication Date Title
CY1125826T1 (el) Ενωσεις αναστολεις της βητα-λακταμασης
PL3185911T3 (pl) Zestaw do znakowania radioizotopowego 68CA zawierający inhibitor metalu
IL263586A (en) Inhibitors of the menin-mll interaction
ME03325B (me) Inhibitor aurora a kinaze
EP3919224C0 (en) MAGNETIC TOOL HOLDER
HUE042335T2 (hu) ROR-gamma dihidropirrolopiridin inhibitorai
HUE046273T2 (hu) Ciklopropilaminok mint LSD1 inhibitorok
HUE045725T2 (hu) Ciklopropilaminok mint LSD1 inhibitorok
LT3137169T (lt) Lizinui specifinės demetilazės-1 inhibitoriai
HUE050564T2 (hu) Lizinspecifikus demetiláz-1 inhibitorai
LT3511319T (lt) Lizinui specifinės demetilazės-1 inhibitoriai
EP3562487A4 (en) METALLOENZYME INHIBITORS
DK3186242T3 (da) Alfa-amino-beta-carboxymuconsyre-semialdehyd-decarboxylasehæmmere
DK3240767T3 (da) Mikroindkapslede nitrifikationshæmmersammensætninger
DK3114120T3 (da) Tetrazolon-substituerede dihydropyridinon-mgat2-hæmmere
GB201403536D0 (en) Inhibitor compounds
HUE066987T2 (hu) Szelektív il-6-transz-szignalizációt gátló szert tartalmazó készítmények
DE112015003457A5 (de) Al-Gusslegierung
DK3137437T3 (da) Mikroindkapslet nitrifikationsinhibitorsammensætning
DE112016001806A5 (de) Bausatz
EP3362587C0 (en) CORROSION INHIBITOR
CL2016003154A1 (es) Composiciones herbicidas sólidas que contienen un fitoprotector
GB201401005D0 (en) Inhibitor
BR112016029865A2 (pt) liga ferrosa
EP3300716A4 (en) Biofilm formation INHIBITORS